Page last updated: 2024-09-05

phosphatidylcholines and Prostatic Neoplasms

phosphatidylcholines has been researched along with Prostatic Neoplasms in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19902 (9.09)18.7374
1990's0 (0.00)18.2507
2000's6 (27.27)29.6817
2010's9 (40.91)24.3611
2020's5 (22.73)2.80

Authors

AuthorsStudies
Adamczyk, P; Buszewska-Forajta, M; Buszewski, B; Król-Górniak, A; Markuszewski, MJ; Monedeiro, F; Pomastowski, P1
Anastassopoulou, J; Eleftheriou, K; Kaminari, A; Panagiotaki, KN; Sideratou, Z; Tsiourvas, D; Zachariadis, M1
Badie, C; Candéias, SM; Cherradi, N; Cruz-Garcia, L; Frey, B; Gaipl, US; Jelonek, K; Lumniczky, K; Mika, J; Napieralska, A; Polanska, J; Polozov, S; Roelants, C; Testard, I; Widlak, P1
Akamatsu, S; Fujita, K; Goto, T; Hayashi, Y; Inoue, T; Kimura, H; Kobayashi, T; Li, X; Nakayama, K; Nonomura, N; Ogawa, O; Shimizu, K1
Botta, M; Calabresi, L; Ferri, N; Franceschini, G; Giorgio, E; Gomaraschi, M; Macchi, C; Magni, P; Ruscica, M1
Chen, M; Dai, Z; Gao, C; Liang, X; Mao, Y; Qiu, C; Qu, E; Wang, X; Yin, T; You, Y; Zheng, R1
Abdallah, OY; Elnaggar, YS; Youssef, SF1
Achaintre, D; Agudo, A; Appleby, PN; Ardanaz, E; Assi, N; Boeing, H; Bueno-de-Mesquita, B; Chirlaque, MD; Fensom, GK; Ferrari, P; Gicquiau, A; Gunter, MJ; Kaaks, R; Karakatsani, A; Key, TJ; Kühn, T; Larrañaga, N; Palli, D; Peppa, E; Perez-Cornago, A; Riboli, E; Rinaldi, S; Sánchez, MJ; Scalbert, A; Schmidt, JA; Sieri, S; Travis, RC; Trichopoulou, A; Tsilidis, KK; Tumino, R1
Gao, L; Quan, D; Wang, T; Zhang, G1
Chandra-Kuntal, K; Glasgow, W; Kelavkar, U; Patel, N; Vogel, R1
Baker, A; Booher, CL; Burch, TC; Isaac, G; Langridge, J; Nyalwidhe, JO; Rainville, P; Rhim, JS1
Arthur, G; Bittman, R; Byun, HS; Samadder, P1
Accardo, A; Aloj, L; Aurilio, M; Cicala, C; De Rosa, G; Maione, F; Morelli, G; Morisco, A; Parisi, A; Salsano, G; Tesauro, D1
Chan, JM; Giovannucci, EL; Kenfield, SA; Richman, EL; Stampfer, MJ; Willett, WC; Zeisel, SH1
Berquin, IM; Chen, YQ; Daniel, LW; Edwards, IJ; O'flaherty, JT; Rudel, LL; Sun, H; Thomas, MJ; Wykle, RL1
Agarwal, R; Crighton, F; Flaig, TW; Glodé, LM; Gustafson, DL; Harrison, GS; Pierson, AS; Su, LJ; Zirrolli, JA1
Brown, K; Gescher, AJ; Greaves, P; Marsden, DA; Patel, K; Steward, WP; Verschoyle, RD1
Edwards, RE; Farmer, PB; Gant, TW; Gescher, AJ; Greaves, P; Jones, DJ; Keun, HC; Steward, WP; Teahan, O; Teichert, F; Verschoyle, RD; Wilson, ID1
Ackerstaff, E; Bhujwalla, ZM; Nelson, JB; Pflug, BR1
Bonfil, RD1
Kontturi, M; Sotaniemi, E1
Lee, LM1

Trials

1 trial(s) available for phosphatidylcholines and Prostatic Neoplasms

ArticleYear
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.
    Investigational new drugs, 2007, Volume: 25, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Excipients; Follow-Up Studies; Gastrointestinal Diseases; Glucuronides; Humans; Liver Function Tests; Male; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet

2007

Other Studies

21 other study(ies) available for phosphatidylcholines and Prostatic Neoplasms

ArticleYear
New approach in determination of urinary diagnostic markers for prostate cancer by MALDI-TOF/MS.
    Talanta, 2022, Jan-01, Volume: 236

    Topics: Humans; Male; Phosphatidylcholines; Prostatic Neoplasms; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triglycerides

2022
A combination drug delivery system employing thermosensitive liposomes for enhanced cell penetration and improved in vitro efficacy.
    International journal of pharmaceutics, 2020, Jan-25, Volume: 574

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Delivery Systems; Drug Liberation; Hot Temperature; Humans; Hyperthermia, Induced; Lipids; Liposomes; Male; PC-3 Cells; Phosphatidylcholines; Prostatic Neoplasms; Temperature

2020
Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2020, Volume: 196, Issue:11

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biomarkers; Cytokines; Gene Expression Regulation, Neoplastic; HLA Antigens; Humans; Immune System; Inflammation Mediators; Lysophosphatidylcholines; Male; Metabolome; Middle Aged; Monocytes; Neoplasm Proteins; Phosphatidylcholines; Prostatic Neoplasms; Proteome; Radiosurgery; Radiotherapy, Intensity-Modulated; Stress, Physiological

2020
High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer.
    Cancer science, 2021, Volume: 112, Issue:10

    Topics: Aged; Biomarkers, Tumor; Humans; Lysophosphatidylcholines; Lysophospholipids; Male; Phosphatidylcholines; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2021
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation.
    Scientific reports, 2018, 02-02, Volume: 8, Issue:1

    Topics: Antioxidants; Apolipoprotein A-I; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Healthy Volunteers; Humans; Hydrogen Peroxide; Lipoproteins, HDL; Male; Oxidative Stress; PC-3 Cells; Phosphatidylcholines; Prostatic Neoplasms; RNA Interference; RNA, Small Interfering

2018
Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
    Theranostics, 2018, Volume: 8, Issue:6

    Topics: Animals; Cell Line, Tumor; Cholesterol; Combined Modality Therapy; Contrast Media; Humans; Male; Mice; Mice, Nude; Microbubbles; Nanoparticles; Phosphatidylcholines; Phosphatidylethanolamines; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Surgery, Computer-Assisted; Theranostic Nanomedicine; Ultrasonography; Xenograft Model Antitumor Assays

2018
Elaboration of polymersomes versus conventional liposomes for improving oral bioavailability of the anticancer flutamide.
    Nanomedicine (London, England), 2018, Volume: 13, Issue:23

    Topics: Animals; Antineoplastic Agents, Hormonal; Biological Availability; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Flutamide; Liposomes; Male; Particle Size; Phosphatidylcholines; Polyesters; Polyethylene Glycols; Prostatic Neoplasms; Rats, Sprague-Dawley; Solubility; Surface Properties

2018
Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
    International journal of cancer, 2020, 02-01, Volume: 146, Issue:3

    Topics: Aged; Biomarkers, Tumor; Case-Control Studies; Follow-Up Studies; Humans; Male; Metabolomics; Middle Aged; Neoplasm Staging; Nutrition Assessment; Phosphatidylcholines; Prospective Studies; Prostate; Prostatic Neoplasms; Risk Factors; Sphingomyelins

2020
Oral delivery of oil-based formulation for a novel synthetic cationic peptide of GnRH (gonadotropin-releasing hormone) antagonist for prostate cancer treatment.
    International journal of pharmaceutics, 2013, Jun-25, Volume: 450, Issue:1-2

    Topics: Administration, Oral; Animals; Castor Oil; Castration; Gonadotropin-Releasing Hormone; Hormone Antagonists; Male; Oligopeptides; Pancreatin; Pepsin A; Phosphatidylcholines; Phosphatidylglycerols; Propylene Glycol; Prostatic Neoplasms; Rats; Rats, Wistar; Testosterone

2013
A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Early Diagnosis; Humans; Male; Middle Aged; Neoplasm Grading; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sphingomyelins

2014
Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Blotting, Western; Cell Line, Tumor; Choline Kinase; Chromatography, Liquid; Gene Expression Regulation, Neoplastic; Humans; Inositol Phosphates; Lipid Metabolism; Lipids; Male; Metabolome; Metabolomics; Middle Aged; Phenotype; Phosphatidylcholines; Phosphatidylethanolamines; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tandem Mass Spectrometry; Transcriptome

2015
Synthesis and antitumor activity of ether glycerophospholipids bearing a carbamate moiety at the sn-2 position: selective sensitivity against prostate cancer cell lines.
    ChemMedChem, 2010, Jul-05, Volume: 5, Issue:7

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Carbamates; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Injections, Intravenous; Male; Membrane Potential, Mitochondrial; Mice; Phosphatidylcholines; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2010
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Animals; Antineoplastic Agents; Bombesin; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Pentetic Acid; Peptide Fragments; Phosphatidylcholines; Prostatic Neoplasms; Receptors, Bombesin; Surface-Active Agents; Xenograft Model Antitumor Assays

2012
Choline intake and risk of lethal prostate cancer: incidence and survival.
    The American journal of clinical nutrition, 2012, Volume: 96, Issue:4

    Topics: Adult; Aged; Betaine; Choline; Cohort Studies; Diet; Disease Progression; Follow-Up Studies; Health Personnel; Humans; Incidence; Male; Middle Aged; Phosphatidylcholines; Phosphorylcholine; Prospective Studies; Prostatic Neoplasms; Risk; Sphingomyelins; Survival Analysis; United States

2012
Differential effects of delivery of omega-3 fatty acids to human cancer cells by low-density lipoproteins versus albumin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Dec-15, Volume: 10, Issue:24

    Topics: Albumins; Animals; Apoptosis; Breast Neoplasms; Cell Proliferation; Chlorocebus aethiops; Cholesterol; Drug Delivery Systems; Fatty Acids, Omega-3; Female; Fish Oils; Gene Expression Profiling; Humans; Linoleic Acid; Lipoproteins, LDL; Male; Oligonucleotide Array Sequence Analysis; Phosphatidylcholines; Phosphatidylethanolamines; Prostatic Neoplasms; Triglycerides; Tumor Cells, Cultured

2004
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
    European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:6

    Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Chromatography, High Pressure Liquid; Drug Evaluation; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin

2008
Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
    The Prostate, 2008, Jul-01, Volume: 68, Issue:10

    Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Choline; Choline Kinase; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Glycerylphosphorylcholine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nuclear Magnetic Resonance, Biomolecular; Oligonucleotide Array Sequence Analysis; Phosphatidylcholines; Phospholipids; Phosphorylcholine; Prostate; Prostatic Neoplasms; Protons

2008
Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells.
    Cancer research, 2001, May-01, Volume: 61, Issue:9

    Topics: Androgens; Cell Line; Cell Transformation, Neoplastic; Choline; Epithelial Cells; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nuclear Magnetic Resonance, Biomolecular; Phosphatidylcholines; Phosphorylcholine; Prostate; Prostatic Neoplasms; Receptors, Androgen

2001
CT-2584 (Cell Therapeutics).
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:3

    Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Drugs, Investigational; Enzyme Inhibitors; Fatigue; Hematuria; Humans; Male; Molecular Structure; Phosphatidic Acids; Phosphatidylcholines; Phospholipase D; Prostatic Neoplasms; Sarcoma; Tumor Cells, Cultured; Xanthines

2001
Thromboembolism during estrogen therapy of prostatic cancer. Report on two cases.
    Scandinavian journal of urology and nephrology, 1971, Volume: 5, Issue:2

    Topics: Adenosine Triphosphatases; Adult; Age Factors; Aged; Anticholesteremic Agents; Anticoagulants; Blood Coagulation Factors; Blood Glucose; Blood Platelets; Carcinoma; Cardiovascular System; Castration; Contraceptives, Oral; Estrogens; Female; Glucose Tolerance Test; Humans; Hypercholesterolemia; Leg; Lipids; Liver; Male; Medroxyprogesterone; Middle Aged; Myocardial Infarction; Phlebography; Phosphatidylcholines; Prostatic Neoplasms; Thromboembolism; Thrombophlebitis

1971
Serum phospholipids in neoplastic disorders.
    Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 32, Issue:1

    Topics: Acid Phosphatase; Alkaline Phosphatase; Bilirubin; Colonic Neoplasms; Esophageal Neoplasms; Humans; Kidney Neoplasms; Leukemia, Myeloid; Liver Neoplasms; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms; Pancreatic Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Prostatic Neoplasms; Rectal Neoplasms; Sphingolipids; Stomach Neoplasms; Thyroid Neoplasms; Triglycerides; Urinary Bladder Neoplasms

1971